DK1103252T3 - Oral farmaceutisk sammensætning af en forbindelse med en afsvampningsaktivitet og fremgangsmåde til fremstilling deraf - Google Patents

Oral farmaceutisk sammensætning af en forbindelse med en afsvampningsaktivitet og fremgangsmåde til fremstilling deraf

Info

Publication number: DK1103252T3
Authority: DK; Denmark
Prior art keywords: compound; coat; activity; preparation; pharmaceutical composition
Prior art date: 1998-07-21

Application number

DK99931261T

Other languages

Danish (da)

English (en)

Inventor

Darder Carlos Picornell

Original Assignee

Liconsa Liberacion Controlada

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-21

Filing date

1999-07-20

Publication date

2003-07-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1103252(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-07-20 Application filed by Liconsa Liberacion Controlada filed Critical Liconsa Liberacion Controlada

2003-07-14 Application granted granted Critical

2003-07-14 Publication of DK1103252T3 publication Critical patent/DK1103252T3/da

Links

150000001875 compounds Chemical class 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
239000008203 oral pharmaceutical composition Substances 0.000 title 1
230000001716 anti-fugal effect Effects 0.000 abstract 3
239000011248 coating agent Substances 0.000 abstract 2
238000000576 coating method Methods 0.000 abstract 2
229920001477 hydrophilic polymer Polymers 0.000 abstract 2
238000002663 nebulization Methods 0.000 abstract 2
239000002736 nonionic surfactant Substances 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 1
238000001035 drying Methods 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

DK99931261T 1998-07-21 1999-07-20 Oral farmaceutisk sammensætning af en forbindelse med en afsvampningsaktivitet og fremgangsmåde til fremstilling deraf DK1103252T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES009801539A ES2157731B1 (es)	1998-07-21	1998-07-21	Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es)	1998-07-21	1999-07-20	Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (1)

Publication Number	Publication Date
DK1103252T3 true DK1103252T3 (da)	2003-07-14

Family

ID=8304581

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99931261T DK1103252T3 (da)	1998-07-21	1999-07-20	Oral farmaceutisk sammensætning af en forbindelse med en afsvampningsaktivitet og fremgangsmåde til fremstilling deraf

Country Status (30)

Country	Link
US (1)	US6737082B1 (de)
EP (1)	EP1103252B1 (de)
JP (1)	JP4190732B2 (de)
KR (1)	KR100572135B1 (de)
AT (1)	ATE234077T1 (de)
AU (1)	AU750730B2 (de)
BG (1)	BG65187B1 (de)
BR (1)	BR9912300A (de)
CA (1)	CA2337509C (de)
CZ (1)	CZ291938B6 (de)
DE (1)	DE69905905T2 (de)
DK (1)	DK1103252T3 (de)
EE (1)	EE04415B1 (de)
ES (2)	ES2157731B1 (de)
HR (1)	HRP20010128B1 (de)
HU (1)	HU228895B1 (de)
IL (1)	IL140910A (de)
ME (1)	MEP26708A (de)
MX (1)	MXPA01000681A (de)
NO (1)	NO320054B1 (de)
NZ (1)	NZ509886A (de)
PL (1)	PL194740B1 (de)
PT (1)	PT1103252E (de)
RS (1)	RS50063B (de)
RU (1)	RU2209628C2 (de)
SK (1)	SK283279B6 (de)
TR (1)	TR200100177T2 (de)
UA (1)	UA64009C2 (de)
WO (1)	WO2000004881A1 (de)
ZA (1)	ZA200101293B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1122456C (zh) *	1996-01-31	2003-10-01	南亚拉巴马医学科学基金会	含有天然的还原叶酸盐异构体的食品和维生素制品
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DZ3227A1 (fr)	1999-12-23	2001-07-05	Pfizer Prod Inc	Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
FR2842736B1 (fr)	2002-07-26	2005-07-22	Flamel Tech Sa	Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) *	2002-12-17	2004-06-17	Lipocine, Inc.	Hydrophobic active agent compositions and methods
DK1438961T4 (da) *	2003-01-14	2014-11-17	Acino Pharma Ag	Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
SI1438960T2 (sl) *	2003-01-14	2013-04-30	Cimex Pharma Ag	Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljĹˇano biorazpoloĹľljivostjo
FR2852607B1 (fr) *	2003-03-20	2006-07-14		Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) *	2003-07-17	2007-11-02	Ethypharm Sa	Particules comprenant un principe actif sous forme de co-precipite
CN1822843B (zh) *	2003-07-17	2010-04-28	泰博特克药品有限公司	制备含有抗病毒药物颗粒的方法
FR2883179B1 (fr)	2005-03-18	2009-04-17	Ethypharm Sa	Comprime enrobe
US8653083B2 (en)	2005-08-22	2014-02-18	The Johns Hopkins University	Hedgehog pathway antagonists to treat disease
CN101283984B (zh) *	2007-04-12	2010-05-26	永胜药品工业股份有限公司	高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en)	2009-01-08	2022-04-19	Chandrashekar Giliyar	Steroidal compositions
JP2013521249A (ja) *	2010-03-05	2013-06-10	ビーエーエスエフソシエタス・ヨーロピア	融解物で被覆された医薬形態
US9358241B2 (en)	2010-11-30	2016-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9034858B2 (en)	2010-11-30	2015-05-19	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20180153904A1 (en)	2010-11-30	2018-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20120148675A1 (en)	2010-12-10	2012-06-14	Basawaraj Chickmath	Testosterone undecanoate compositions
US9498485B2 (en)	2014-08-28	2016-11-22	Lipocine Inc.	Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en)	2014-08-28	2017-08-31	Lipocine Inc.	(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
MA40982A (fr) *	2014-11-19	2017-09-26	Biogen Ma Inc	Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
WO2016189481A1 (en) *	2015-05-25	2016-12-01	Sun Pharmaceutical Industries Limited	Once daily oral pharmaceutical composition of isotretinoin
US20160361322A1 (en)	2015-06-15	2016-12-15	Lipocine Inc.	Composition and method for oral delivery of androgen prodrugs
KR102419769B1 (ko)	2016-08-11	2022-07-13	아다미스 파마슈티칼스 코포레이션	약물 조성물
US20180147215A1 (en)	2016-11-28	2018-05-31	Lipocine Inc.	Oral testosterone undecanoate therapy
EP3720844A4 (de)	2017-12-08	2021-08-11	Adamis Pharmaceuticals Corporation	Arzneimittelzusammensetzungen
WO2019208801A1 (ja) *	2018-04-27	2019-10-31	凸版印刷株式会社	徐放性複合粒子、徐放性複合粒子の製造方法、乾燥粉体及び壁紙
US12150945B2 (en)	2018-07-20	2024-11-26	Lipocine Inc.	Liver disease
EP4452232A1 (de) *	2021-12-22	2024-10-30	Palau Pharma, S.L.U.	Multipartikuläre albaconazolzusammensetzung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4267179A (en) *	1978-06-23	1981-05-12	Janssen Pharmaceutica, N.V.	Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) *	1987-03-25	1990-04-10	Janssen Pharmacuetica N.V.	4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) *	1990-07-04	1994-11-16	Zambon Spa	Programmed release oral solid pharmaceutical dosage form
PH30929A (en) *	1992-09-03	1997-12-23	Janssen Pharmaceutica Nv	Beads having a core coated with an antifungal and a polymer.
TW349870B (en) *	1993-09-30	1999-01-11	Janssen Pharmaceutica Nv	An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
US5567441A (en) *	1995-03-24	1996-10-22	Andrx Pharmaceuticals Inc.	Diltiazem controlled release formulation
DK0904060T3 (da) *	1996-05-20	2004-04-13	Janssen Pharmaceutica Nv	Antifungale præparater med forbedret biotilgængelighed
ZA974428B (en) *	1996-05-24	1997-11-24	Schering Corp	Antifungal composition with enhanced bioavailability.
NZ333514A (en) *	1996-06-28	2000-05-26	Schering Corp	Oral pharmaceutical composition comprising a triazole antifungal compound
DE19626924C2 (de) *	1996-07-04	1999-08-19	Epazon B V	Gerät zur Bereitstellung eines Atemgases
WO1998042318A1 (en)	1997-03-26	1998-10-01	Janssen Pharmaceutica N.V.	Pellets having a core coated with an antifungal and a polymer

1998
- 1998-07-21 ES ES009801539A patent/ES2157731B1/es not_active Expired - Fee Related
1999
- 1999-07-20 UA UA2001021260A patent/UA64009C2/uk unknown
- 1999-07-20 TR TR2001/00177T patent/TR200100177T2/xx unknown
- 1999-07-20 BR BR9912300-2A patent/BR9912300A/pt not_active Application Discontinuation
- 1999-07-20 ME MEP-267/08A patent/MEP26708A/xx unknown
- 1999-07-20 RU RU2001104894/14A patent/RU2209628C2/ru not_active IP Right Cessation
- 1999-07-20 EE EEP200100041A patent/EE04415B1/xx not_active IP Right Cessation
- 1999-07-20 US US09/744,322 patent/US6737082B1/en not_active Expired - Fee Related
- 1999-07-20 RS YUP-39/01A patent/RS50063B/sr unknown
- 1999-07-20 JP JP2000560874A patent/JP4190732B2/ja not_active Expired - Fee Related
- 1999-07-20 SK SK86-2001A patent/SK283279B6/sk not_active IP Right Cessation
- 1999-07-20 WO PCT/ES1999/000230 patent/WO2000004881A1/es not_active Ceased
- 1999-07-20 HR HR20010128A patent/HRP20010128B1/xx not_active IP Right Cessation
- 1999-07-20 KR KR1020017000783A patent/KR100572135B1/ko not_active Expired - Fee Related
- 1999-07-20 AU AU47821/99A patent/AU750730B2/en not_active Ceased
- 1999-07-20 AT AT99931261T patent/ATE234077T1/de active
- 1999-07-20 CA CA002337509A patent/CA2337509C/en not_active Expired - Fee Related
- 1999-07-20 CZ CZ2001175A patent/CZ291938B6/cs not_active IP Right Cessation
- 1999-07-20 ES ES99931261T patent/ES2194480T3/es not_active Expired - Lifetime
- 1999-07-20 PL PL99345625A patent/PL194740B1/pl not_active IP Right Cessation
- 1999-07-20 NZ NZ509886A patent/NZ509886A/xx not_active IP Right Cessation
- 1999-07-20 DK DK99931261T patent/DK1103252T3/da active
- 1999-07-20 HU HU0103708A patent/HU228895B1/hu not_active IP Right Cessation
- 1999-07-20 DE DE69905905T patent/DE69905905T2/de not_active Expired - Lifetime
- 1999-07-20 MX MXPA01000681A patent/MXPA01000681A/es active IP Right Grant
- 1999-07-20 PT PT99931261T patent/PT1103252E/pt unknown
- 1999-07-20 IL IL14091099A patent/IL140910A/en not_active IP Right Cessation
- 1999-07-20 EP EP99931261A patent/EP1103252B1/de not_active Expired - Lifetime
2001
- 2001-01-17 NO NO20010289A patent/NO320054B1/no not_active IP Right Cessation
- 2001-02-15 ZA ZA200101293A patent/ZA200101293B/en unknown
- 2001-02-21 BG BG105282A patent/BG65187B1/bg unknown

Also Published As

Publication number	Publication date
ZA200101293B (en)	2001-08-21
HK1037531A1 (en)	2002-02-15
JP2002521323A (ja)	2002-07-16
NO20010289D0 (no)	2001-01-17
KR20010070990A (ko)	2001-07-28
PT1103252E (pt)	2003-07-31
KR100572135B1 (ko)	2006-04-19
YU3901A (sh)	2003-08-29
EE200100041A (et)	2002-06-17
BR9912300A (pt)	2001-04-17
HU228895B1 (en)	2013-06-28
BG105282A (en)	2001-11-30
EE04415B1 (et)	2005-02-15
CZ2001175A3 (en)	2001-05-16
IL140910A0 (en)	2002-02-10
RU2209628C2 (ru)	2003-08-10
ES2194480T3 (es)	2003-11-16
BG65187B1 (bg)	2007-06-29
IL140910A (en)	2004-03-28
US6737082B1 (en)	2004-05-18
CA2337509A1 (en)	2000-02-03
CZ291938B6 (cs)	2003-06-18
SK862001A3 (en)	2001-08-06
DE69905905D1 (de)	2003-04-17
CA2337509C (en)	2005-12-27
NZ509886A (en)	2002-09-27
RS50063B (sr)	2009-01-22
ES2157731A1 (es)	2001-08-16
NO320054B1 (no)	2005-10-17
EP1103252B1 (de)	2003-03-12
AU750730B2 (en)	2002-07-25
HRP20010128B1 (en)	2003-12-31
WO2000004881A1 (es)	2000-02-03
ATE234077T1 (de)	2003-03-15
HRP20010128A2 (en)	2002-12-31
MEP26708A (en)	2010-06-10
TR200100177T2 (tr)	2001-07-23
HUP0103708A3 (en)	2002-07-29
ES2157731B1 (es)	2002-05-01
JP4190732B2 (ja)	2008-12-03
HUP0103708A2 (hu)	2002-02-28
PL194740B1 (pl)	2007-06-29
UA64009C2 (en)	2004-02-16
EP1103252A1 (de)	2001-05-30
PL345625A1 (en)	2002-01-02
NO20010289L (no)	2001-03-07
MXPA01000681A (es)	2002-04-24
DE69905905T2 (de)	2004-03-04
SK283279B6 (sk)	2003-05-02
AU4782199A (en)	2000-02-14

Publication	Publication Date	Title
NO20010289D0 (no)	2001-01-17	Oral farmasöytisk sammensetning med en forbindelse som har antisopp aktivitet og en metode for dens fremstilling
DK1059848T3 (da)	2005-03-29	Dragéret tyggegummi, fremgangsmåde til fremstilling hraf samt anvendelse af et eller flere aktive stoffer i fast form
DE69431807D1 (de)	2003-01-09	Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
AU2940200A (en)	2000-09-28	Hydrophilic member, method for preparation thereof, and coating agent and apparatus for preparation thereof
NL194637B (nl)	2002-06-03	Werkwijze voor het vervaardigen van deeltjes, bedoeld voor het over een verloop van tijd afgeven van een effectieve hoeveelheid actief bestanddeel.
CA2348398A1 (en)	2001-03-29	Water-soluble coating agents bearing initiator groups and coating process
CA2146680A1 (en)	1995-12-24	Cleaning wafer substrates of metal contamination while maintaining wafer smoothness
BR9915087A (pt)	2001-07-17	Formulação farmacêutica oral revestida entérica, uso de uma qualidade de hidroxipropil celulose (hpc), processo para a munufatura de uma formulação farmacêutica oral revestida entérica, uso de uma formulação farmacêutica, e, método para o tratamento de doenças gastrointestinais em mamìferos, incluindo o homem
DE60006504D1 (de)	2003-12-18	Aufbringung von substanzen auf feste gegenstände im in-line verfahren
FR2767070B1 (fr)	1999-09-17	Composition visqueuses aqueuses, limpides ou non, pour la fabrication de capsules molles et de capsules dures, et procede de fabrication de films pour de telles capsules
DK76892A (da)	1993-12-11	Genstand med friktionsnedsaettende overfladebelaegning samt fremgangsmaade til fremstilling af en saadan belagt genstand
NO20000284D0 (no)	2000-01-20	Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
DK0868912T3 (da)	2003-01-06	Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
ATE97567T1 (de)	1993-12-15	Eine suspension hydratisierter spheroide einer hydrophilen lipidsubstanz enthaltendes waessriges kosmetisches bzw. dermopharmazeutisches mittel.
IT1295645B1 (it)	1999-05-24	Apparecchio per l'elettroemanazione di principi attivi.
DE60133028D1 (de)	2008-04-10	Mikrogranulat auf wirkstoffbasis und verfahren zu seiner herstellung
IE900391L (en)	1990-08-03	N-(3-pyridyl) guanidine derivative
DE69532983D1 (de)	2004-06-09	Überzogene pestizide Mittel, Verfahren zu deren Herstellung sowie diese enthaltende Mittel
FI952251L (fi)	1995-05-09	Menetelmä enantiomeerisesti puhtaan 6-((4-kloorifenyyli)-(1H-triatsoli-1,2,4-triatsol-1-yyli)metyyli)-1-metyyli-1H-bentsotriatsolin valmistamiseksi
JPS51136732A (en)	1976-11-26	Method for curing photo-curable coating composition
FR2727701B3 (fr)	1996-12-27	Composition de revetement pour pistes, d'hippisme notamment
JPS5581138A (en)	1980-06-18	Manufacturing of feed roller
FR2757856B1 (fr)	2000-06-02	Compose, procede pour sa preparation, composition herbicide le contenant, et son utilisation